As Washington debates how to reshape health care and Americans struggle to pay for lifesaving drugs, The Atlantic will host a discussion focused on exploring value-based drug pricing.
The Atlantic gathered key stakeholders to examine the future for biosimilars domestically and abroad.
The Atlantic will convene experts for a discussion of the rare disease patient experience and why it is so unique.
We sat down with Atlantic senior editor James Hamblin to discuss his new book, If Our Bodies Could Talk: A Guide to Operating and Maintaining a Human Body, a handbook for tackling life’s most pressing health concerns and curiosities.
The Atlantic will gather key stakeholders to examine the emerging world of biosimilars and their regulatory framework in the United States.
The Secretary of Defense Ash Carter sat down with The Atlantic’s Editor in Chief Jeffrey Goldberg in a wide ranging conversation on the state of the US military, its role in the world and its future both home and abroad.
Since the turn of the 20th century, average life expectancy has been rising steadily. In the United States, we can now expect to live an average of three decades longer than our great-grandparents. As we collectively age, our societal understandings of the rhythms of an average lifespan have been slow to adapt. With nearly 10,000 baby boomers moving into retirement every day, The Atlantic examined the shape of the new old age and its impact on society.
The Atlantic convened discussions with urban leaders and entrepreneurs on the role of cities in facing today's biggest global health challenges.
The Summit probed systemic challenges facing the nation's mental heath care and worked to identify groundbreaking treatments within reach.